LeMaitre Q2 EPS $0.52 +44%, FY guidance raised; dividend $0.16

LEMAITRE VASCULAR INC

2024-Q2 EPS reported $0.96 revenue$109,327,000

Sales $55.8M +11% (+12% organic); EPS $0.52 +44% vs Q2 2023.
Gross margin 68.9% (+490 bps); operating income $14.4M +52%.
Allografts +30%, bovine patches +12%, carotid shunts +22% led growth.
Q3 guidance: sales $52.7-54.7M, EPS $0.42-0.46; FY guidance raised to sales $218.8M, EPS $1.82-1.91.
Quarterly dividend $0.16/share payable Aug 29, record Aug 15.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.